Preferred Label : Seizures, benign familial neonatal, 2;
Symbol : BFNS2;
CISMeF acronym : BFNC2; BFNS2;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Convulsions, benign familial neonatal, 2; BFNC2;
Description : Benign familial neonatal seizures-2 is an autosomal dominant neurologic condition
characterized by onset of clonic or tonic-clonic seizures in the first few days of
life. Seizures tend to last for about a minute, may occur several times a day, and
are responsive to medication. Almost all patients have full remission within the first
months of life, although some rare patients may have a few seizures later in childhood.
EEG, brain imaging, and psychomotor development are usually normal (summary by Fister
et al., 2013). For a general phenotypic description and a discussion of genetic heterogeneity
of benign familial neonatal seizures, see BFNS1 (121200).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the potassium voltage-gated channel, KQT-like subfamily, member
3 gene (KCNQ3, 602232.0001);
Prefixed ID : #121201;
Origin ID : 121201;
UMLS CUI : C1852581;
Automatic exact mappings (from CISMeF team)
Broader ORDO disease(s)
DO Cross reference
Genes related to phenotype
HPO term(s)
Not associated HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)